Sitemap > Breaking Research > Metabolic & Hormonal Disorders
Displaying 651 - 700 of 3753 results
- Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal dopamine D1 receptor hyperphosphorylation, and restores D1 receptor-G-protein coupling and function in obese Zucker rats.
- Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin.
- Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
- Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.
- Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.
- Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project.
- Guidelines for the management of osteoporosis: the present and the future.
- Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
- Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma.
- The changing epidemiology of diabetic microangiopathy in type 1 diabetes.
- Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation.
- Novel antiglaucoma prodrugs and codrugs of ethacrynic acid.
- Renal tissue factor expression is increased in streptozotocin-induced diabetic mice.
- Curcumin attenuates diet-induced hypercholesterolemia in rats.
- Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes.
- Erythropoietin attenuated high glucose-induced apoptosis in cultured human aortic endothelial cells.
- Contribution of site-specific PEGylation to the dipeptidyl peptidase IV stability of glucose-dependent insulinotropic polypeptide.
- Synthesis and evaluation of photolabile insulin prodrugs.
- Synthesis of long-chain amide analogs of the cannabinoid CB1 receptor antagonist N-(piperidinyl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716) with unique binding selectivities and pharmacological activities.
- Protective role for cytosolic phospholipase A2alpha in autoimmune diabetes of mice.
- A new retinoid-like compound that activates peroxisome proliferator-activated receptors and lowers blood glucose in diabetic mice.
- Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue.
- Changes in aortic endothelial gene expressions and relaxation responses following chronic short-term insulin treatment in diabetic rats.
- Atorvastatin induces insulin sensitization in Zucker lean and fatty rats.
- Effects of a beta-blocker on bone turnover in normal postmenopausal women: a randomized controlled trial.
- Circulating androgen levels and self-reported sexual function in women.
- Adamantyl cannabinoids: a novel class of cannabinergic ligands.
- Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study.
- Tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population.
- Lead optimization of 4-(dimethylamino)quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1.
- Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation.
- A new selective estrogen receptor modulator with potent uterine antagonist activity, agonist activity in bone, and minimal ovarian stimulation.
- Adipose tissue transplantation protects ob/ob mice from obesity, normalizes insulin sensitivity and restores fertility.
- IL-4 inhibits bone-resorbing activity of mature osteoclasts by affecting NF-kappa B and Ca2+ signaling.
- Selective inhibition of Fcepsilon RI-mediated mast cell activation by a truncated variant of Cbl-b related to the rat model of type 1 diabetes mellitus.
- Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis.
- Design and syntheses of melanocortin subtype-4 receptor agonists. Part 2: discovery of the dihydropyridazinone motif.
- PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1.
- Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.
- An in vivo model to study osteogenic gene regulation: targeting an avian retroviral receptor (TVA) to bone with the bone sialoprotein (BSP) promoter.
- Effects of S21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients.
- The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance.
- Insulin resistance in cognitive impairment: the InCHIANTI study.
- Amelioration of diabetic dyslipidemia by macrocyclic binuclear oxovanadium complex on streptozotocin induced diabetic rats.
- Tissue-specific expression and dimerization of the endoplasmic reticulum oxidoreductase Ero1beta.
- Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
- A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cells.
- Influence of atorvastatin on apolipoprotein E and AI kinetics in patients with type 2 diabetes.
- The neuroprotection of insulin on ischemic brain injury in rat hippocampus through negative regulation of JNK signaling pathway by PI3K/Akt activation.
- Modulation of angiogenesis during adipose tissue development in murine models of obesity.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 Next >